Abstract:Lung cancer is the second most common cancer in all genders, whereas the most common subtype of lung cancer is non–small cell lung cancer (NSCLC), a leading cause of death among other malignancies. 1,2 Knowledge of prognosis prior to treatment and during the treatment can be useful to change or optimize the treatment strategy or prevent other posttreatment. Radiomics analysis aims to convert medical images to high-dimensional data, which could be connected to a desired target, such as biopsy results for clinical diagnosis and patient outcome for prognostic and predictive models. 3–5 Radiomics information coupled with machine learning (ML) algorithms showed potential to predict the prognosis for NSCLC patients after treatment, 6,7 whereas most of the available studies using artificial intelligence (AI) 7–9 focused on radiomic features extracted from the tumoral region and used clinical information, such as age, gender, and blood tests as additional information. Amini et al 9 developed ML models to predict survival using different image fusion strategies and radiomics extracted from the gross tumor volume (GTV) on the same population. 8 Lee et al 10 extracted peritumoral image features and reported gain in classification performance, which depends on tumor size. Hosny et al 11 showed that deep learning classification algorithms emphasized the importance of peritumoral tissue in patient risk estimation. Perez-Morales et al 12 used peritumoral and intratumoral radiomic features to detect a vulnerable subset of lung cancer patients associated with poor survival outcomes who may require aggressive follow-up and/or adjuvant therapy. Mattonen et al 13 reported the importance of metabolic tumor volume penumbra extended by 1 cm in NSCLC recurrence. Guo et al 14 evaluated the predictive value of dosiomics and CT radiomics of esophageal tumor GTV and whole esophagus for predicting complications after radiotherapy. They reported the combination of GTV and whole esophagus as the best predictor using ML models. Lam et al 15 used multiomics data including radiomics and dosiomics extracted from 8 volumes of interest irradiated around the nasopharyngeal GTV to predict the adaptive radiotherapy eligibility in nasopharyngeal cancer patients. They reported the best performance for radiomics plus dosiomics extracted from these 8 regions plus the GTV. They did not compare the GTV only versus added value of the surrounding organs. Girum et al 16 reported that the position of lesions relative to spleen has additional predictive value in lymphoma patients treated with radiopharmaceutical therapy. During the COVID-19 pandemic, few studies reported the importance of gastrointestinal finding in predicting patient prognosis. 17,18 Szabo et al 19 reported the importance of pericardiac fat in the prognostic prediction of patients with heart failure.

Organomics: A Concept Reflecting the Importance of PET/CT Healthy Organ Radiomics in Non–Small Cell Lung Cancer Prognosis Prediction Using Machine Learning

Organomics: A concept reflecting the importance of PET/CT healthy organ radiomics in non-small cell lung cancer prognosis prediction using machine learning

A Radiomic Approach to Access Tumor Immune Status by CD8<SUP>+</SUP>TRMs on Surgically Resected Non-Small-Cell Lung Cancer

Radiomics Model Based on Intratumoral and Peritumoral Features for Predicting Major Pathological Response in Non-Small Cell Lung Cancer Receiving Neoadjuvant Immunochemotherapy

Prognostic Prediction of Cancer Based on Radiomics Features of Diagnostic Imaging: The Performance of Machine Learning Strategies

Prognostic Value and Pathological Correlation of Peritumoral Radiomics in Surgically Resected Non-Small Cell Lung Cancer

Machine Learning-Based Prediction of Pathological Responses and Prognosis After Neoadjuvant Chemotherapy for Non–Small-Cell Lung Cancer: A Retrospective Study

PET/CT radiomics and machine learning enable non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinoma

Potential of radiomics analysis and machine learning for predicting brain metastasis in newly diagnosed lung cancer patients

Could the underlying biological basis of prognostic radiomics and deep learning signatures be explored in patients with lung cancer? A systematic review

Effect of machine learning methods on predicting NSCLC overall survival time based on Radiomics analysis

A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study

Multimodal radiomics-based methods using deep learning for prediction of brain metastasis in non-small cell lung cancer with 18F-FDG PET/CT images

Noninvasive Method for Predicting the Expression of Ki67 and Prognosis in Non-Small-Cell Lung Cancer Patients: Radiomics

Enhancing Survival Outcome Predictions in Metastatic Non-Small Cell Lung Cancer Through PET Radiomics Analysis

Body Composition and Radiomics from 18F-FDG PET/CT Together Help Predict Prognosis for Patients with Stage IV Non-Small Cell Lung Cancer.

Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics

Radiotranscriptomics of non-small cell lung carcinoma for assessing high-level clinical outcomes using a machine learning-derived multi-modal signature

Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT

Radiomics-Clinical AI Model with Probability Weighted Strategy for Prognosis Prediction in Non-Small Cell Lung Cancer

Improved Prognostication of Overall Survival after Radiotherapy in Lung Cancer Patients by an Interpretable Machine Learning Model Integrating Lung and Tumor Radiomics and Clinical Parameters